Jefferies Financial Group Inc. Invests $15.02 Million in Omada Health, Inc. $OMDA

Jefferies Financial Group Inc. bought a new stake in Omada Health, Inc. (NASDAQ:OMDA) during the second quarter, Holdings Channel reports. The institutional investor bought 684,091 shares of the company’s stock, valued at approximately $15,016,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Perceptive Advisors LLC acquired a new stake in Omada Health during the 2nd quarter worth $44,402,000. BlackRock Inc. acquired a new position in Omada Health in the second quarter valued at $48,775,000. Millennium Management LLC raised its holdings in shares of Omada Health by 1,195.0% in the fourth quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock valued at $35,855,000 after buying an additional 2,096,705 shares during the last quarter. SG Americas Securities LLC acquired a new stake in shares of Omada Health during the first quarter worth about $10,401,000. Finally, Madryn Asset Management LP purchased a new position in shares of Omada Health during the fourth quarter worth about $9,212,000.

Insider Buying and Selling at Omada Health

In related news, CFO Steven L. Cook sold 33,000 shares of the stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $19.89, for a total transaction of $656,370.00. Following the transaction, the chief financial officer directly owned 133,359 shares in the company, valued at approximately $2,652,510.51. This represents a 19.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Sean P. Duffy sold 25,886 shares of Omada Health stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $22.68, for a total value of $587,094.48. Following the completion of the sale, the chief executive officer owned 411,861 shares of the company’s stock, valued at $9,341,007.48. This trade represents a 5.91% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 254,726 shares of company stock valued at $5,370,496 over the last quarter. Insiders own 6.38% of the company’s stock.

Wall Street Analysts Forecast Growth

OMDA has been the subject of several analyst reports. Wells Fargo & Company upped their price objective on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Weiss Ratings raised Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a report on Tuesday, August 11th. BTIG Research upped their price target on Omada Health from $30.00 to $35.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $28.00 price target on shares of Omada Health in a report on Friday, May 8th. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Omada Health currently has an average rating of “Moderate Buy” and a consensus price target of $26.50.

Omada Health Price Performance

Shares of NASDAQ OMDA opened at $24.27 on Friday. The company has a 50-day simple moving average of $22.15 and a 200-day simple moving average of $17.11. The company has a market cap of $1.49 billion, a PE ratio of 485.40 and a beta of 1.73. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92.

Omada Health (NASDAQ:OMDA) last announced its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. The firm had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. On average, analysts anticipate that Omada Health, Inc. will post 0.09 EPS for the current year.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.